Increasing drug resistant tuberculosis in the UK

Last week proposals in the UK to lower the 24 week deadline for abortion were rejected in the House of Commons. Decisions involving late abortion and the care of extremely preterm infants often result from strongly held beliefs rather than evidence. To a large extent this is understandable as these decisions are personal. However, when moral judgments are imposed on those holding different views and when the rights of the infant, be it to life or death, are in danger of colliding with those of parents and society the need for evidence is paramount.In the linked study, Field and colleagues compare survival figures for two adjacent time periods, 1994-9 and 2000-5, for infants born at a gestational age of 22 weeks to 25 weeks and six days in a geographically defined region of the United Kingdom, the former Trent health region.

[1]  E. Oger,et al.  Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study , 2007, Circulation.

[2]  Alexander M. Walker,et al.  Venous Thromboembolism, Myocardial Infarction, and Stroke Among Transdermal Contraceptive System Users , 2007, Obstetrics and gynecology.

[3]  A. Reiner,et al.  Conjugated Equine Estrogen, Esterified Estrogen, Prothrombotic Variants, and the Risk of Venous Thrombosis in Postmenopausal Women , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[4]  F. Stanczyk,et al.  Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins. , 2006, Contraception.

[5]  R. Langer,et al.  Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus , 2006, Archives of internal medicine.

[6]  M. W. van den Heuvel,et al.  Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. , 2005, Contraception.

[7]  H. Nelson.  Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. , 2004, JAMA.

[8]  P. Schofield,et al.  A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study , 2002, BJOG : an international journal of obstetrics and gynaecology.

[9]  H. Arnesen,et al.  Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement Therapy , 2000, Thrombosis and Haemostasis.